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Introduction
The pain and distress which animals experience as a consequence
of their use by man figures prominently in discussions of animal welfare.
Some improvements have been made in animal housing and husbandry
practices and it is likely that further progress will be made in this
field. In comparison, relatively little attention has been given to the
problem of minimizing the pain and distress caused to animals by the
various procedures to which they are subjected. The most publicized of
these are the wide range of experimental techniques which are undertaken using laboratory animals, but also includes procedures such as
castration of farm animals and neutering operations carried out on pet
animals. The prevention or alleviation of the pain associated with such
procedures is a complex problem with no single, simple solution. Consideration must be given to the use of analgesic drugs, the provision
of high standards of general care, and the use of special nursing
techniques. When dealing with post-operative care, the pre-operative
management ofthe animal, the operative procedures and the anesthetic
regime must all be evaluated and, when necessary, modified to minimize
pain or discomfort.

Pain Perception in Animals
It is generally accepted that animals perceive and react to pain in
a manner similar to man, although the conscious experience of pain may
61
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well vary in different animal species and man (Melzack and Dennis
1980; Moloney 1985). Our inability to define precisely the nature of the
sensation of pain leads to difficulties, both in its assessment and in
recommending methods of pain relief. In man, the common assessment
of pain is based mostly on the subjective criterion that "pain is what
the patient says hurts" (Smith 1984). In animals, a variety of definitions
has been proposed, however as yet none of these are entirely satisfactory
(Uvarov 1985).
Although pain is more easily detected in man than in animals, the
standard of pain relief following surgery in man is generally poor, with
some 40-50 percent of patients receiving inadequate analgesia following
surgery (Smith 1984). In a recent survey of the incidence of post-operative pain in children, only 25 percent were found to be pain-free
immediately following surgery (Mather and Mackie 1983). In seems
reasonable to assume that given the additional difficulties of detection
of pain, and the generally lower level of nursing care, that an even
greater percentage of animals will experience post-operative pain. The
failure to provide adequate pain relief in man has been attributed to
a number of factors, including a lack of awareness of the problem by
the medical staff concerned and a fear of the undesirable side-effects,
such as respiratory depression, which are associated with the use of
opiates. It seems likely that similar factors are involved in the provision
of pain relief in animals.
If the standard of pain relief for animals is to be improved, it is
important to ensure that the possibility of pain in animals is acknowledged, that the staff concerned are trained to recognize pain and distress in animals, and that effective methods of pain relief are employed
wherever possible.
In addition to the desirability of relieving pain on humane grounds,
pain also has other adverse effects, for example, movement is restricted
and food and water intake are depressed. Pain has also been shown to
cause widespread vasoconstriction and perpetuate the metabolic and
hormonal changes induced by surgery (Kehlet 1978).

Recognition of Pain in Animals
The response of animals to pain varies considerably and it is difficult
to offer definitive criteria for the assessment of pain in different animal
species. There are, however, a range of behavioral changes that are
frequently associated with pain and these are often helpful in determining its degree and thus whether analgesics are required.
In general, animals which are in pain are relatively inactive and
may remain completely immobile within their cage or pen. When
observed undisturbed, alterations in the pattern or rate of respiration
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may be noted, and on examination the heart rate may be elevated. If
the animal moves it will often have an abnormal gait and when
approached or handled may be uncharacteristically aggressive. If the
painful area is confined to one limb joint or to a surgical wound, then
the animal will usually attempt to prevent the area from being handled
and may react violently to attempts to manipulate it. When left undisturbed, the animal may position itself to observe the painful area, and
may lick or groom the area excessively. Alternatively, normal grooming
behavior may be absent, and as a consequence the coat may appear
dirty and unkempt.
Pain may cause the adoption of an abnormal posture, for example
a "tucked up" appearance produced by tensing the muscles of the abdomen and back. Animals may also become unusually restless, moving
about constantly, or continuously getting up and laying down. Very
abnormal behavior such as flailing or extensor rigidity of the limbs,
writhing or production of self-inflicted bite wounds, indicates severe
pain. Similar behavior may, of course, occur in the immediate post-operative period during recovery from anesthesia, before the animal becomes
fully conscious. If, however, such behavior persists when the animal
has fully recovered from the anesthetic, then it must be assumed to be
experiencing severe pain which must be relieved. If such pain cannot
be alleviated rapidly, a decision must be taken as to whether the animal
should be humanely killed immediately.
Animals in pain frequently reduce their food and water intake,
often to the extent that serious dehydration occurs. If pain persists for
a prolonged period, the reduction in food and water intake will result
in a fall in body weight which may be a useful index for the assessment
of chronic pain, and also for monitoring the efficacy of any analgesia.
Abnormal vocalization may occur-dogs may whine or whimper,
cats miaow and cry, or occasionally may purr, rats squeak at an unusual
pitch, and primates may scream or grunt when moving. It must be
appreciated that vocalization may be elicited in response to non-painful
stimuli. For example, the squeals of pigs in response to handling, or in
anticipation of feeding, might be interpreted as indicative of pain by
those unfamiliar with the normal behavior of the species.
All of the criteria above must be considered in conjunction with the
nature of any surgical procedure which has been undertaken, or the characteristics of any disease processes which may be present. As mentioned
above, it is also important to be aware of the normal behavioral characteristics of the particular animal species. It is especially useful to discuss the
appearance of an individual animal with its owner or handler, since many
of the changes in demeanor may be extremely subtle, and apparent
only to someone who is very familiar with the animal's previous behavior.
The clinical assessment of pain, distress, and discomfort has been
described in small mammals (Morton 1985), dogs and cats (Taylor 1985),
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horses (Silver 1985), ruminants (Edwards 1985), pigs (Oldham 1985), poultry and birds (Gentle 1985), primates (Tribe 1985), and fish (Brown 1985).
A technique for assessing pain by means of a scoring system based
on clinical observation has been described by Morton and Griffiths
(1985). The assessment system catalogues a range of clinical signs such
as reduced food and water intake, altered posture, change in temperament, and altered respiration and pulse rate. Deviations of these signs
from normal are scored according to the severity of the deviation. The
total score from all of the listed clinical signs provides an overall assessment of the animal, a high score indicating that pain or distress is
likely to be present. This proposed scoring system utilizes many clinical
signs that could be produced by other, non-painful factors. Despite this
drawback, an animal which has a high score is quite obviously abnormal,
and should receive careful attention.
When considering chronic pain of gradual onset, many of the
behavioral changes may be ascribed to other factors. A pet dog with a
tumor may be thought lethargic and depressed as a consequence of
natural aging rather than the pain caused by the tumor. Administration
of an analgesic to such animals may result in a marked improvement
in its "quality of life" (Yoxall 1978).
It is apparent that although the behavior of animals in pain may
be dramatic, in some the response may be so slight as to be almost
inapparent to all but those most familiar with the behavior patterns
both of the animal species involved, and of the individual animal. Such
familiarity is difficult to achieve, and in many instances there will be
considerable doubt as to whether an animal is in pain. For this reason
it is the author's practice to assume that a procedure or injury which
is likely to cause pain in man will also cause pain in an animal. Such
anthropomorphic views are open to criticism, and ignore the issue of
what significance the animal attaches to its pain. It is possible that
the apparent tolerance of injuries that would be acutely painful in man
may involve a greater suppression of central pain perception in some
animal species. Until unequivocal evidence is produced to support such
views, it is obviously more humane to assume that pain is present, and
to make every attempt to provide effective pain relief.

Pain Relief in Animals
In most instances pain relief will be provided by the use of analgesic
drugs. Although the use of such agents will control pain, an animal may
still exhibit signs of distress. Semantic difficulties abound in the field of
animal welfare, and numerous definitions of stress and distress have
been proposed. In this paper the term "distress" is used to describe the
state produced by adverse factors which would not usually be considered

Recognition and Alleviation of Pain

65

to cause pain, but are certainly unpleasant and should be avoided. For
example, a cold, wet environment, devoid of suitable bedding material
is likely to cause distress to some animal species. Similarly, states of
physiological imbalance, such as dehydration caused by inadequate
fluid therapy, would not be referred to as painful, but would cause
distress. It seems reasonable to include methods aimed at reducing
distress in the management of pain. It is also assumed by the author
that pain and distress can be heightened by fear or apprehension, and
any regime of nursing care must include reassurance and calming of
the animal, either by personal contact, environmental manipulations,
or by pharmacological means. In addition to analgesics, a range of other
drugs including tranquilizers, sedatives, and corticosteroids or similar
agents with anti-inflammatory activity may all play a role in the management of pain.

Analgesic Drugs
Of the wide variety of analgesics available for use in man, relatively
few have been employed in routine veterinary clinical practice. A certain
amount of published information concerning the suitability of analgesics
for veterinary use is available, and in many instances the original
assessment of a drug's properties in experimental animals provides
useful data (Flecknell 1984).

Centrally Acting Analgesics

Nareotics: Agonists
This group of drugs includes the best established veterinary analgesics pethidine (meperidine) and morphine. All are potent analgesics
but also produce some undesirable effects on the central nervous system,
respiratory depression being of the most clinical significance. Most of
the side-effects can be reversed by the use of specific antagonists (see
below), although this will, of course, reverse any analgesia which has
been produced.

Morphine
Morphine has been used in veterinary practice in the United Kingdom for some years (Hall and Clarke 1983), and its efficacy in the dog
has been recently confirmed by Taylor and Houlton (1984). It is an
effective analgesic in a wide range of species (table 1), but its undesirable
side-effects can include severe respiratory depression and overdosage
can cause incoordination or excitement in some species (cat, Davis and
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Donnelly 1968, Lumb and Jones 1984; mouse, Pearl et al. 1969, Lumb
and Jones 1984) or narcosis in others (dog, primate, rabbit, Lumb and
Jones 1984).

Pethidine (Meperidine)
This drug is perhaps the most widely used veterinary analgesic
and suitable dose rates have been established for a range of species
(table 1), although its respiratory depressant effect can limit its use,
particularly in the immediate post-operative period. In addition,
pethidine has a relatively short duration of action in some species, for
example, less than two hours in the cat (Davis and Donnelly 1968).
Methadone
Clinical use of methadone in the dog has been largely restricted
to pre-anesthetic medication (1 mg/kg, i/v or s/c*) (Lumb and Jones
1984). In the horse, in combination with acepromazine (50 mg
methadone and 50 mg acepromazine total dose/1000 lb horse), it has
been reported to provide effective sedation (Schauffier 1969). The
analgesic action of the drug in horses appears variable, although some
beneficial effect could be demonstrated (Pippi and Lumb 1979).
D-Propoxyphene
D-Propoxyphene is structurally related to methadone, but has considerably less analgesic potency. It has been recommended for the relief
of mild to moderate pain in the dog at a suggested dose of 16.25 mg
b.i.d. per os** for small dogs, up to 32 mg/kg t.i.d. t for larger breeds
(Yoxall 1978). In the author's experience it is useful at these dose rates
for the relief of musculoskeletal pain in this species.
Codeine and dihydrocodeine
These two morphine derivatives have been used to a limited extent
in small animals. Oral preparations of codeine may be of use for the
control of mild pain in the dog at a dose of 2 mg/kg (Taylor 1985).
Fentanyl and etorphine
Fentanyl and etorphine are two extremely potent analgesics which
have been widely used as components of neuroleptanalgesics, and their
use for this purpose has been reviewed by Green (1979). The short

* i/v-by intravenous injection
sic-subcutaneous injection

** b.i.d.

per os-twice a day by mouth

t t.i.d.-three times

a day.
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duration of action of fentanyl limits its value as an analgesic when
given by intermittent injection, but it is potentially useful for administration by continuous intravenous infusion (see later).

New Opiates
Alfentanil resembles fentanyl in almost all its pharmacological and
clinical effects. It differs in having a very short duration of action (about
ten minutes in the rat, Niemegeers 1977), making it especially suitable
for administration by continuous intravenous infusion.
Lofentanil, a novel, extremely potent narcotic analgesic, has the
longest duration of action of any drug of this group so far discovered.
It appears unlikely that the drug will be introduced into human clinical
practice, but a drug having such a long duration of action might prove
extremely useful in providing analgesia in animals.
Carfentanil, another member of the fentanyl group of analgesics, has a
potency thirty-two times that offentanyl (i.e., about 18,000 times as potent
as pethidine). It has been used for the immobilization of wild animals
where its high potency enables its use in low volumes (< 1 m1 for most
large animals, DeVos 1978). It has also been used in combination with
etomidate as an anesthetic in guinea pigs (Neumann et al. 1980).

Narcotics: Partial Agonists
This group of drugs has mixed morphine-like analgesic and antagonist
properties. They were developed primarily in an attempt to produce
analgesic drugs free from morphine's undesirable side-effects, and in
particular to avoid the problem of the development of addiction.

Pentazocine
Pentazocine has been used to a limited extent in veterinary clinical
practice. Its use in the dog to control post-operative pain has been
reported by Cooper and Organ (1977) and Taylor and Houlton (1984).
It is the author's experience that it can be used effectively to relieve
acute pain in nonhuman primates (table 1).
Buprenorphine
This potent, long-lasting analgesic appears to offer several advantages
compared to many of the agents mentioned above. Although controlled
studies in animals are limited to experimental data in rodents (Heel
et al. 1979; Cowan et al. 1977a, 1977b) and a clinical trial in the dog
(Taylor and Houlton 1984), the drug has been used clinically in both
laboratory and companion animals. Its use in the horse has been
reported by Hall and Clarke (1983), and it has been used to provide
effective pain relief in a wide range of species by the author (table 1).
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Buprenorphine's efficacy in producing pain relieffollowing acute trauma
or surgery has also been established in small animal practice in the
United Kingdom.
This drug has a considerably longer duration action in most species
(> 8 hours) than the other agents described above. In addition, it seems
to produce fewer and less marked side-effects.

Butorphanol
This drug has similar pharmacological properties to pentazocine
(House 1979), but a somewhat greater potency (Heel et al. 1978). Information concerning its effects in animals is limited (Pircio et al. 1976).
Its administration to the horse has been described by Robertson et al.
(1981), although its analgesic effects were not evaluated.
Nalbuphine
Nalbuphine has proven to be an eflfective analgesic in acute and
chronic painful conditions in man, with fewer undesirable side-effects
than morphine. Its analgesic action has been studied in mice and rats
(Blumberg et al. 1968), however, it would appear to be a potentially
useful drug in the dog, since in this species the plasma half-life is 8.3
hours (Fahmy 1983), suggesting that the agent may produce long-lasting
analgesia.

Other Analgesic Drugs
A range of low to moderate potency compounds such as aspirin,
paracetamol (acetaminophen), and phenacetin are widely used in man
to control mild pain. Their use in veterinary practice is limited but
these compounds are often administered to pet animals by their owners.
Such uncontrolled administration can have serious consequences. Aspirin and paracetamol may both be rapidly and fatally toxic to cats
(Wilkinson 1984). In dogs, aspirin is extremely irritant to the gastric
mucosa (Davison et al. 1966) and it is preferable to use other preparations such as paracetamol and codeine in this species.

Anti-Inflammatory Agents
Corticosteroids are the drugs most widely used in veterinary practice for the reduction of chronic or acute inflammatory responses. By
reducing the degree of inflammation, they diminish the pain associated
with such a reaction, but have no specific analgesic action. They are
useful in treating conditions in which pain is the result of tissue inflammation. However, since the inflammatory response is a prerequisite for
successful healing of damaged tissue, they must be used with caution.
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A number of non-steroidal anti-inflammatory drugs have been
developed, the most widely used in veterinary practice being phenylbutazone. Phenylbutazone has proven particularly useful in the control
of musculoskeletal pain in the dog and the horse, however, its numerous
undesirable side-effects may limit its use (Yoxall 1978). Other drugs
have been introduced into human clinical practice, and some of these
have been used in veterinary practice in the United Kingdom (Taylor
1985). lbruprofen has been recommended for use in the dog, an initial
loading dose of 30 mg/kg per os* in divided doses, followed by a maintenance dose of 16 mg/kg being suggested by Yoxall (1978).

'Iranquilizers
This group of drugs has no intrinsic analgesic action, and when
used alone they may actually increase pain perception. When administered in conjunction with a narcotic analgesic they will potentiate the
effects of the latter. The combination of sedation, analgesia, and a
reduction in fear and apprehension is extremely useful, particularly
immediately following surgery or trauma. The degree of sedation produced varies considerably in different animal species, for example,
diazepam, a sedative which can be used to induce hypnosis (sleep) in
man, has little sedative action in the dog, but in rodents and rabbits
it produces marked sedation.

Clinical Use of Analgesics
As has been indicated above, the use of analgesics in animals is
hampered by the lack of information concerning suitable dose rates and
by practical problems associated with drug administration. A major
problem with most analgesics is their short duration of action (1-4
hours), so that maintenance of adequate analgesia requires repeated
administration of the drug, which is often difficult to arrange in practice.
Buprenorphine, unlike other narcotic analgesics, has been shown to
have a duration of action of at least 10-14 hours in both animals and
man. Veterinary clinical use of this agent has shown that it is effective
in controlling severe post-operative pain for at least 10-14 hours. Since
buprenorphine has some narcotic antagonistic activity, it can be used
to reverse the narcosis produced by neuroleptanalgesic combinations
(e.g., fentanyl!fluanisone and fentanyl/droperidol) and yet maintain
effective post-operative analgesia.
Slow release preparations of analgesics have been developed for
experimental use, (Laska and Fennessy 1978; Frederickson and Smiths

* per os-by

mouth
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1973; McGinity and Mehta 1978), and it would seem feasible to adapt
such techniques to provide long-term analgesia. A slow-release morphine
preparation for oral administration has become available in the United
Kingdom (MST Continus; Napp Laboratories Ltd.), and has been shown
to provide up to six hours pain relief in man (Fell et al. 1982). A sustainedrelease morphine preparation for intramuscular or subcutaneous injection is also marketed (Duromorph, LAB Ltd.), however, no information
is available concerning the use of either of these products in animals,
although they would appear to be potentially useful preparations.
An alternative method of providing effective pain relief is to use a continuous drug delivery system such as a chronically implanted catheter
and a suitable swivel apparatus. The use of continuous intravenous infusion of opiates has been evaluated clinically in man (see review by Mather
1983) and shown to be considerably more effective in providing pain relief
than intermittent injections. When using the intravenous route, administration of a drug such as alfentanil, with a short duration of action,
enables rapid variation in plasma concentrations should undesirable
side-effects occur. In most animal applications, however, the technique
will be used to provide analgesia for prolonged periods (for example,
overnight) in the absence of nursing staff. Under these circumstances,
the main factors influencing the choice of drug will be its therapeutic
index and the volume of solution required. If the volume of drug required
is small, a light-weight portable infusion pump can be used, bandaged
directly to the animal. It is also usually more convenient to use the
subcutaneous route of administration. Although this does not enable
rapid variations in plasma levels to be achieved should undesirable
side-effects occur, it is a much easier technique to instigate and maintain.
When calculating the dose rates required, as a general guide, following administration of an initial standard dose, the quantity of drug
needed for continuous infusion will be about half that which would be
given by intermittent injection. The animal should, of course, be
observed carefully to determine that effective analgesia is being acheived
and that undesirable effects, such as respiratory depression, are minimal. When pharmacokinetic data are available for the drug and the
animal species concerned, more accurate estimation of infusion rates
are possible, and these techniques are reviewed by Mather (1983).

Undesirable Effects of Narcotic Analgesics
Excessive doses of narcotic analgesics can cause severe respiratory
depression, requiring assisted ventilation or reversal with an antagonist
such as naloxone. Opiate antagonists, of course, reverse any analgesia
that has been produced as well as reversing the respiratory
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depression, so that it may be preferable to use a specific respiratory
stimulant such as doxapram. Doxapram has a relatively short duration
of action (fifteen to twenty minutes), and either repeated doses or a
continuous infusion of the drug may be needed to maintain adequate
stimulation of respiration. Use of buprenorphine in animals appears
to carry little risk of producing respiratory depression. However, if this
does occur, doxapram should be used since naloxone is relatively ineffective in reversing the depressant effeCts of buprenorphine.
Paradoxically, the potent action of narcotics in abolishing pain has
been cited as a disadvantage of their use in clinical veterinary practice.
Pain, of course, serves a protective function in discouraging movement
of a traumatized area, and so tending to minimize further injury. Complete abolition of pain in the post-operative period has been suggested
as likely to lead to disruption of sutures by excessive activity. This is
rarely, if ever, a problem providing good wound closure techniques have
been used. Excessive activity can be controlled, if necessary, by the
addition of a tranquilizer to the post-operative drug regime, and use
of appropriate bandaging and splinting techniques can provide additional wound support.
It is the author's view that analgesics should never be withheld on
such grounds as those described above. Clinical experience has shown
that effective use of analgesics, rather than resulting in tissue damage
due to excessive activity, will often prevent undue self-trauma of the
affected area.

Additional Components of the Management of Pain
The control of pain requires more than simply the administration
of an appropriate analgesic. If a surgical procedure is to be undertaken,
it may be useful to include an opiate such as pethidine in any preanesthetic medication to provide pain relief in the immediate post-operative period. If surgery is prolonged, however(> 2 hours), the analgesic
effects of the drug will no longer be apparent and a period of acute
pain may follow emergence from the anesthetic, unless prompt administration of an analgesic is ensured. This may be avoided to some extent
by the use of an anesthetic agent such as methoxyflurane which has
been shown to have limited analgesic properties in the post-operative
period (Vickers et al. 1984). Alternatively, the technique of reversal of
a neuroleptanalgesic combination with a partial agonist such as buprenorphine can be used to try to ensure a completely pain-free emergence
from anesthesia.
The pain caused by surgical procedures can, of course, be reduced
by good technique, particularly that directed at minimizing tissue trauma.
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Preventing tension on suture lines, immobilizing fractures and
traumatized tissue, and padding and protecting surgical wounds considerably reduces post-operative pain.
Provision of a special area for recovery from anesthesia and for
post-operative nursing is of importance. This enables more appropriate
environmental conditions to be maintained and encourages individual
attention and special nursing-all important factors in minimizing
pain and discomfort.
Such an area should be warm (approximately 25-30 degrees Centigrade for adult animals of most species), draught-free, and quiet.
Hypothermia is a common problem during post-operative recovery and
a heating pad or heating lamp may be required to provide additional
warmth. It is also useful to reduce heat losses by insulating the animal
by providing additional bedding materials and by use of specialized
blankets. Body temperature should be monitored to ensure that the
measures employed are effective, and also to avoid overheating and
consequent hyperthermia. Fluid intake is frequently reduced post-operatively so that where appropriate oral intake should be encouraged and
hand feeding of fluids undertaken whenever necessary. If these simple
measures prove inadequate, dehydration must be corrected by parenteral administration of fluids. Food intake should also be monitored
carefully, and supplemented by hand feeding if required.
In all species, every effort should be made to keep the animal clean
and dry, since this is more comfortable for the animal and encourages
closer attention from the nursing staff. There is little point in preventing
pain by the use of analgesics if the animal is uncomfortable and distressed by inappropriate or inadequate post-operative care.
If an animal appears apprehensive, reassurance by personal contact
will be effective only in animals which are accustomed to such attentions.
Even in these species, and certainly in the case of many laboratory
species, use of tranquilizers may be considered necessary.

Future Development
In man, a range of new approaches to the management of pain are
being developed. Whilst many of these are unlikely to be routinely used
in animals, others hold considerable promise. One technique that may
prove particularly useful is the administration of opiates by the intrathecal or epidural routes. This technique has been employed clinically
in man and extensively investigated in experimental animals (see
reviews by Yaksh 1981, 1983). The technique involves implantation of
an epidural or intrathecal catheter to allow repeated administration of
small quantities of opiates such as morphine. Profound, long-lasting
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analgesia is produced, for example, 12-16 hours following intrathecal
morphine in primates (Yaksh 1981). The areas of the body rendered
analgesic depend upon the spinal cord level reached by the opiate. In
most instances the technique has been used to produce analgesia of
the abdomen and hindquarters, although successful production of
analgesia extending to the forelegs in the dog has been reported by
Cohen et al. (1982). In man the technique has been used to control
pain following a variety of abdominal surgical procedures, lower limb
surgery, and thoracotomy (Camporesi and Redick 1983). The analgesia
produced by epidural and intrathecal opiates is not associated with any
loss of motor function or loss of sensation to touch, unlike the effects
produced by local anesthetics administered by the same routes.
The lower doses of drug used cause few of the systemic effects such
as sedation, which develop following intramuscular injection of opiates.
Although some undesirable side-effects have been noted including
pruritis (Hales 1980) and urinary retention, the latter does not appear
to be a problem in animals. The most significant side-effect in man has
been the development of severe respiratory depression. The incidence
of this problem is difficult to assess, but is certainly low ( < 0.5 percent,
Reiz et al. 1981; Gustafsson et al. 1982) and has not been noted as a
serious side-effect in the limited clinical or experimental studies in the
dog (Bonath et al. 1984; Cohen et al. 1982). Repeated intrathecal administration of opiates and maintenance of spinal catheters for prolonged
periods (4-16 months) in primates resulted in no demonstrable neurological or pathological changes (Yaksh 1981). It is clear that this technique
could be employed in a wide range of situations in animals, particularly
following experimental surgical procedures. It might also offer a method
of producing long-term analgesia for localized disease processes, or
chronic inflammatory conditions. The method of catheter implantation
has been described in a wide range of species including the rat (Yaksh
and Rudy 1976), the rabbit (Yaksh and Rudy 1976), the cat (Yaksh 1978),
the dog (Cohen et al. 1982; Bonath et al. 1984) and nonhuman primates
(Yaksh 1978; Bahar et al. 1984). In addition, the continuous epidural
infusion of opiates using an implanted pump has been described in the
dog (Cohen et al. 1982) offering the possibility of prolonged analgesia
without the necessity of repeated injections of drug through an
exteriorized spinal catheter.

Conclusions
Considerable opportunity exists for the adoption of better methods
for the management of pain and distress in animals. Experimental
studies in animals and clinical experience in man are likely to continue
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to offer new approaches that can be applied to veterinary clinical practice. Major problems remain, for example, the control of chronic pain,
particularly in laboratory animals where the prolonged use of analgesics
may interfere with the experimental protocol.
The solution of these and other problems requires both the development of new techniques and the better application of existing knowledge.
A change in priorities by all those concerned in the management of
animals is required, with considerably greater emphasis being placed
on the well-being of the animal. Improved education at all levels is
needed to disseminate available knowledge, and to promote a greater
awareness of the needs of the animals given over to our care.
Thble L Analgesic drugs for use in animals.
Morphine

Pethidine

Pentazocine

Buprenorphine

Mouse

lOmg/kgs/c
2-4hourly

20mg/kg s/c i!m
2-3hourly

10mg/kgs/c
3-4hourly

2.0mg/kg* s/c
12hourly

Rat

lOmg/kgs/c
2-4hourly

20mg/kg s/c i/m*
2-3hourly

10mg/kgs/c
4hourly

0.1-0.5mg/kg* s/c
12hourly

Rabbit

5mg/kgs/c
lOmg/kg s/c i!m* 10-20mg/kgs/ci!m 0.02-0.05mg/kg*
2-3hourly
4hourly
sic, i!v 8-12 hourly
i!m 2-4 hourly

Guinea Pig

lOmg/kgs/c
20mg/kg s/c i!m
2-3hourly
i!m 2-4 hourly

Cat

O.lmg/kg/ s/ct 10mg/kg s/c i!m*
4hourly
2hourly

Dog

0.5-5.0mglkgt 10mg/kg s/c i!m* 2. Omg/kg i!m*
2-3 hourly
4hourly
s/c i!m
2-4 hourly

Primate
Pigs
Sheep

1-2mg/kg s/c
4hourly

0.05mg/kg s/c
8-12hourly
8mg/kgi!p
? 4hourly

2-4mg/kg i!m * 2-5.0mg/kg i!m*
3-4hourly
4hourly

Up to
20mg total dose t

2mg/kgi!m*
4 hourly

Up to
10mgtotal
dosei!m t

Up to
200mgtotal
dosei!m t

0.005-0. Olmg/kg*
12 hourly
0.01-0.02mg/kg* i!m
s/c 12 hourly
O.Olmg/kg* i!m i!v
12hourly

2.0mg/kgi!mt 0.005-0.0lmg/kg* ilm
4hourly
12hourly
0.005mg/kg* i!m
12 hourly

Dose rates suggested from published data.
*Clinical experience at the Clinical Research Center, Harrow.
tRecommended dosages in veterinary literature (Lumb and Jones 1984; Green 1979; Hall
and Clark 1983).
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